脳オキシメトリーモニタリング市場- 世界の産業規模、シェア、動向、機会、予測、用途別、エンドユーザー別、地域別セグメント、競合、2019-2029年

世界の脳オキシメトリーモニタリング市場は、2023年に2億197万米ドルと評価され、2029年までのCAGRは6.99%で、予測期間中に着実な成長が予測されています。

脳オキシメトリーは、脳組織内の血液中の酸素飽和度を測定・監視するために使用される医療技術です。脳に供給される酸素量に関するリアルタイムの情報を提供し、手術やその他の医療処置中の脳機能の維持や神経学的合併症の予防に極めて重要です。脳オキシメトリー技術は、近赤外分光法（NIRS）を利用してこれらの測定を行う。脳オキシメトリー装置は近赤外分光法の原理で作動します。これらの装置は額の組織に近赤外光を照射し、その光は組織を通過する際に部分的に吸収・散乱されます。そして装置は、組織を通過した後に戻ってくる光の量を測定します。

光の吸収と散乱パターンを分析することで、血管内の酸素化ヘモグロビンと脱酸素化ヘモグロビンのレベルを推定することができます。心臓手術や神経外科手術のような複雑な手術を含む外科手術の世界の増加により、手術リスクの軽減や患者の転帰の改善に役立つ技術への需要が高まっています。脳オキシメトリーモニタリングは、脳酸素管理を支援することで、このニーズに対応します。高齢化社会は、手術や医療介入を必要とする慢性疾患にかかりやすくなっています。また、高齢の患者は、脳への酸素供給の低下に関連した合併症を起こしやすくなります。脳オキシメトリーモニタリングは、高齢患者のこうしたリスクを管理する上で極めて重要になります。医療機器技術の絶え間ない進歩により、より正確で使いやすく、信頼性の高い脳オキシメトリーモニタリング機器が開発されています。このような技術向上により、技術の採用が増加しています。

主な市場促進要因

手術件数の増加

脳オキシメトリーモニタリング技術の進歩

麻酔システムとの統合

主な市場課題

臨床的有用性の変動

コストと償還

主な市場動向

調査と臨床研究

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の脳オキシメトリーモニタリング市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別（心臓外科、血管外科、その他）
  • エンドユーザー別（病院・診療所、外来手術センター、その他）
  • 企業別（2023）
  • 地域別
• 市場マップ

第6章 北米の脳オキシメトリーモニタリング市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の脳オキシメトリーモニタリング市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の脳オキシメトリーモニタリング市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の脳オキシメトリーモニタリング市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの脳オキシメトリーモニタリング市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Masimo Corp.
• Medtronic Plc
• Edwards Lifesciences Corporation
• Nonin Medical Inc.
• ISS Inc.
• Hamamatsu Corporation
• Mespere LifeSciences, Inc.
• GE HealthCare Technologies, Inc.
• Terumo Cardiovascular Systems Corporation
• Koninklijke Philips N.V.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Cerebral Oximetry Monitoring Market was valued at USD 201.97 million in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 6.99% through 2029. Cerebral oximetry is a medical technology used to measure and monitor the oxygen saturation levels in the blood within the brain tissues. It provides real-time information about the amount of oxygen being delivered to the brain, which is crucial for maintaining brain function and preventing neurological complications during surgeries and other medical procedures. Cerebral oximetry technology utilizes near-infrared spectroscopy (NIRS) to achieve these measurements. Cerebral oximetry devices work on the principle of near-infrared spectroscopy. These devices emit near-infrared light into the tissues of the forehead, and the light is partially absorbed and scattered as it passes through the tissue. The device then measures the amount of light that is returned after passing through the tissue.

By analyzing the absorption and scattering patterns of the light, the device can estimate the levels of oxygenated and deoxygenated hemoglobin in the blood vessels. The global increase in surgical procedures, including complex surgeries like cardiac and neurosurgical procedures, has driven the demand for technologies that can help mitigate surgical risks and improve patient outcomes. Cerebral oximetry monitoring addresses this need by aiding in brain oxygenation management. The aging population is more prone to chronic conditions that require surgeries and medical interventions. Older patients are also more susceptible to complications related to reduced oxygen supply to the brain. Cerebral oximetry monitoring becomes crucial in managing these risks in elderly patients. Continuous advancements in medical device technology have led to the development of more accurate, user-friendly, and reliable cerebral oximetry monitoring devices. These technological improvements increase the adoption of technology.

Key Market Drivers

Growing Number of Surgeries

The growing number of surgeries globally is a significant healthcare trend that has been observed over the past several years. This is influenced by various factors, including changes in demographics, increased access to healthcare services, advancements in medical technology, and evolving treatment approaches. The global population is aging, and older individuals are more likely to require surgical interventions due to age-related health issues. As life expectancy increases, the demand for surgeries to address conditions like cardiovascular diseases, joint replacements, and cancer treatment also rises. The prevalence of non-communicable diseases such as heart disease, diabetes, and cancer has been increasing worldwide. Many of these conditions require surgical interventions as part of treatment plans, contributing to the overall rise in surgical procedures. Improved access to healthcare services, particularly in developing countries, has led to an increase in the number of individuals seeking medical treatment, including surgeries. This is driven by efforts to expand healthcare infrastructure and reduce disparities in access.

Advances in medical technology have expanded the range of surgical procedures that can be performed with minimally invasive techniques. This has made surgeries less invasive, with shorter recovery times, encouraging more patients to opt for surgical interventions. Surgical techniques and approaches continue to evolve, making surgeries more effective and safer. As surgical outcomes improve and risks are minimized, patients and healthcare providers are more inclined to consider surgical options. Some surgical procedures are performed as preventive measures to reduce the risk of future health complications. For example, surgeries to remove precancerous growths or to address conditions like obesity can prevent more serious health issues down the line.

Various global health initiatives and organizations are working to increase access to essential surgeries in low- and middle-income countries. These initiatives aim to address conditions like cataracts, hernias, and obstetric complications that can greatly impact quality of life. The growth of medical tourism, where patients travel to other countries for medical procedures, has contributed to an increase in surgeries in certain regions. Patients seek lower costs, quicker access, or specialized expertise in specific medical destinations. Traumatic injuries and emergencies necessitate surgical interventions for immediate life-saving purposes. The growing population and changing lifestyles can lead to an increase in accidents and trauma cases, driving down the demand for surgical services. Greater awareness about medical conditions and treatment options has led patients and their families to become more proactive in seeking surgical solutions for various health issues. This factor will pace up the demand of Global Cerebral Oximetry Monitoring Market.

Advancements in Cerebral Oximetry Monitoring Technology

Traditional cerebral oximetry devices typically use two wavelengths of light to estimate oxygen saturation. Advanced devices have introduced multi-wavelength systems that use more than two wavelengths. This enables improved accuracy by considering a broader range of optical properties in the tissue. Some cerebral oximetry systems provide regional oxygen saturation mapping, offering insights into oxygenation levels in specific regions of the brain. This allows healthcare professionals to identify potential imbalances in oxygen supply to different brain areas. Many modern cerebral oximetry devices can be integrated with anesthesia delivery systems. This integration enables real-time adjustments to anesthesia levels based on cerebral oxygenation data, optimizing patient safety during surgery. Advancements in connectivity have enabled some devices to offer wireless data transmission and remote monitoring capabilities. This allows healthcare professionals to monitor cerebral oxygenation levels from different locations, enhancing patient care and management. Some cerebral oximetry systems incorporate data analytics and trend monitoring features. They collect and analyze historical data to provide insights into oxygenation trends during surgeries and procedures, assisting medical teams in making informed decisions.

Advanced systems are equipped with automated alert mechanisms that notify healthcare providers when significant changes in cerebral oxygenation are detected. This helps medical teams intervene promptly if oxygen levels deviate from the normal range. Some devices allow healthcare professionals to set customizable threshold values for oxygen saturation. This feature enables personalized monitoring based on patient-specific factors and surgical procedures. Modern cerebral oximetry monitors provide real-time visual feedback to the surgical team, helping them assess the impact of interventions on cerebral oxygenation levels during the procedure. User-friendly interfaces and touchscreen displays have become standard in many cerebral oximetry devices. These interfaces simplify device operation, data interpretation, and navigation for medical professionals. While initially used primarily in cardiac surgeries, cerebral oximetry technology has expanded its clinical applications. Devices are now used in a wider range of surgical procedures, including neurosurgery, vascular surgery, and other critical interventions. Advancements have been made to adapt cerebral oximetry technology for pediatric and neonatal patients. Devices are designed to account for the unique physiological characteristics of these populations. This factor will help in the development of Global Cerebral Oximetry Monitoring Market.

Integration with Anesthesia Systems

Cerebral oximetry integration with anesthesia systems refers to the incorporation of cerebral oximetry monitoring technology into anesthesia delivery systems. This integration aims to enhance patient safety during surgical procedures by providing real-time data on cerebral oxygenation levels and allowing anesthesia providers to make informed decisions to optimize oxygen delivery to the brain. Integrating cerebral oximetry with anesthesia systems enables continuous real-time monitoring of cerebral oxygen saturation (rSO2). This data helps anesthesia providers assess the brain's oxygen supply and adjust as needed. Anesthesia providers can receive alerts and notifications if significant changes in cerebral oxygenation are detected. This allows for prompt intervention to prevent hypoxia or other complications.

By observing how anesthesia affects cerebral oxygenation, anesthesia providers can fine-tune anesthesia levels to ensure optimal oxygen delivery to the brain. This can help reduce the risk of cognitive dysfunction and other adverse outcomes. Different surgical procedures and patients have varying oxygenation requirements. Integration allows anesthesia providers to customize anesthesia management based on individual patient needs and surgical context. By maintaining adequate cerebral oxygenation, the integration of cerebral oximetry with anesthesia systems can contribute to improved patient outcomes, reduced complications, and shorter recovery times. Integration involves connecting the cerebral oximetry monitoring device to the anesthesia system's interface or monitoring platform. The device typically uses non-invasive sensors placed on the patient's forehead to measure oxygen saturation in brain tissues. This factor will accelerate the demand of Global Cerebral Oximetry Monitoring Market.

Key Market Challenges

Variable Clinical Utility

Variable clinical utility is a challenge that has been recognized in the global cerebral oximetry monitoring market. This challenge pertains to the varying degrees of usefulness and appropriateness of cerebral oximetry monitoring technology across different medical procedures, patient populations, and clinical scenarios. Healthcare providers might selectively adopt cerebral oximetry monitoring only in specific high-risk scenarios, leading to inconsistent usage across different procedures. The perceived benefit of cerebral oximetry monitoring may not outweigh the costs in cases where the clinical utility is limited. This could impact its adoption, particularly in less complex procedures. The development of clinical guidelines recommending the use of cerebral oximetry monitoring might face challenges when determining which procedures warrant its implementation.

Cost and Reimbursement

Cost and reimbursement challenges have been significant factors impacting the global cerebral oximetry monitoring market. These challenges can influence the adoption and utilization of cerebral oximetry monitoring technology in various healthcare settings. The initial investment required to purchase cerebral oximetry monitoring equipment can be substantial. This cost includes not only the devices themselves but also any associated accessories, sensors, and software. Healthcare institutions need to allocate resources for training healthcare professionals to effectively use and interpret cerebral oximetry data. Proper training is essential to ensure accurate readings and informed decision-making.

Regular maintenance, calibration, and servicing of cerebral oximetry devices are necessary to ensure their accuracy and reliability. These ongoing costs can add up over time. In some regions or healthcare systems, there might be a lack of established reimbursement mechanisms for cerebral oximetry monitoring procedures. This can discourage healthcare providers from adopting the technology due to financial concerns. Reimbursement policies and rates for cerebral oximetry monitoring may vary depending on factors such as the specific procedure, patient population, and geographical location. This variation can lead to uncertainty for healthcare providers. To secure reimbursement, healthcare providers and manufacturers often need to demonstrate the cost-effectiveness of cerebral oximetry monitoring in terms of improved patient outcomes and reduced post-operative complications. Navigating the approval process for reimbursement can be complex and time-consuming. It may involve providing clinical evidence, demonstrating clinical utility, and addressing regulatory requirements.

Key Market Trends

Research and Clinical Studies

Research and clinical studies contribute to evidence-based practice, influence medical guidelines, and drive the adoption of this technology in various medical specialties. Rigorous research and clinical studies provide scientific evidence regarding the benefits of cerebral oximetry monitoring in different medical scenarios. This evidence guides medical professionals in making informed decisions about the use of the technology. Research studies validate the accuracy and reliability of cerebral oximetry devices in measuring brain oxygenation levels. This validation is essential for gaining the trust of healthcare providers and regulatory bodies. Clinical studies assess how cerebral oximetry monitoring impacts patient outcomes, such as reducing the risk of post-operative complications, cognitive dysfunction, and neurological injuries. Research helps establish the safety and efficacy of cerebral oximetry monitoring technology, addressing concerns and uncertainties that may exist among healthcare professionals.

Many studies focus on evaluating the impact of cerebral oximetry monitoring on patient outcomes during high-risk surgical procedures, such as cardiac surgeries, vascular surgeries, and neurosurgeries. Research investigates the utility of cerebral oximetry monitoring in managing patients with neurological conditions that affect brain oxygenation, such as traumatic brain injury, stroke, and brain hemorrhage. Research examines how integrating cerebral oximetry monitoring with anesthesia systems improves anesthesia management and patient safety during surgeries. Studies explore the correlation between cerebral oxygenation levels during surgeries and post-operative cognitive function, helping understand the long-term impact of oxygenation on brain health. The findings of well-designed research studies influence the development of clinical guidelines and recommendations for the use of cerebral oximetry monitoring in specific medical procedures. Research and clinical studies continue to advance the understanding of cerebral oximetry monitoring technology. Ongoing studies may explore new applications, refine protocols, and provide deeper insights into its benefits across diverse patient populations.

Segmental Insights

Application Insights

Based on application, cardiac surgery emerged as the fastest growing segment in the Global Cerebral Oximetry Monitoring Market in 2023. There is a growing acknowledgment of the significance of monitoring cerebral oxygenation levels during surgeries to prevent brain injury. Healthcare facilities are increasingly integrating cerebral oximetry monitoring systems to augment patient safety and outcomes. While initially predominantly employed in cardiac surgeries, cerebral oximetry monitoring is now being employed in a wider array of surgical procedures, encompassing vascular surgeries, neurosurgeries, and critical care settings. This diversification of applications expands the market potential for cerebral oximetry monitoring devices. Ongoing advancements in technology have facilitated the development of more precise and user-friendly cerebral oximetry monitoring devices. These improvements enhance the reliability and effectiveness of monitoring, thereby stimulating adoption among healthcare providers.

End User Insights

In 2023, the Global Cerebral Oximetry Monitoring was dominated by hospitals & clinics segment and is predicted to continue expanding over the coming years. Cardiac surgeries are recognized as some of the most intricate and perilous surgical procedures. These surgeries involve temporary cessation of the heart, which can compromise blood flow to the brain. Cerebral oximetry monitoring is instrumental in maintaining sufficient oxygenation of the brain during these pivotal stages. According to the National Heart, Lung, and Blood Institute (NHLBI), approximately 2 million open heart surgeries are performed worldwide each year to address various cardiac conditions. Consequently, the anticipated rise in cardiac surgical procedures is expected to fuel the need for cerebral oximetry devices in the foreseeable future.

Regional Insights

The North America region has established itself as the leader in the Global Cerebral Oximetry Monitoring Market in 2023. North America, particularly the United States and Canada, boasts advanced healthcare infrastructure with well-equipped hospitals, research institutions, and medical facilities. This infrastructure enables the adoption and integration of cutting-edge medical technologies like cerebral oximetry monitoring. The region has been an early adopter of medical technologies and innovations. This includes the adoption of cerebral oximetry monitoring in various medical settings, ranging from cardiac surgeries to neonatal care. This is largely due to the presence and offerings of major players in the region, such as Medtronic, Nonin and Masimo. Major providers of O3 oximeter devices in the United States include INVOS System, Foresight, and Root for the monitoring of cerebral desaturation during cardiac surgery in the United States.

Key Market Players

Masimo Corp.

Medtronic Plc

Edwards Lifesciences Corporation

Nonin Medical Inc.

ISS Inc.

Hamamatsu Corporation

Mespere LifeSciences, Inc.

GE HealthCare Technologies, Inc.

Terumo Cardiovascular Systems Corporation

Koninklijke Philips N.V.

Report Scope:

In this report, the Global Cerebral Oximetry Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cerebral Oximetry Monitoring Market, By Application:

Cardiac Surgery Vascular Surgery Others

Cerebral Oximetry Monitoring Market, By End User:

Hospitals & Clinics Ambulatory Surgical centers Others

Cerebral Oximetry Monitoring Market, By Region:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

South Korea

Australia

Japan

Europe

Germany

France

United Kingdom

Spain

Italy

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cerebral Oximetry Monitoring Market.

Available Customizations:

Global Cerebral Oximetry Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cerebral Oximetry Monitoring Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Cardiac Surgery, Vascular Surgery, Others)
  • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Surgical centers, Others)
  • 5.2.3. By Company (2023)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Cerebral Oximetry Monitoring Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cerebral Oximetry Monitoring Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By End User
  • 6.3.2. Mexico Cerebral Oximetry Monitoring Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By End User
  • 6.3.3. Canada Cerebral Oximetry Monitoring Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By End User

7. Europe Cerebral Oximetry Monitoring Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cerebral Oximetry Monitoring Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany Cerebral Oximetry Monitoring Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Cerebral Oximetry Monitoring Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Cerebral Oximetry Monitoring Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Cerebral Oximetry Monitoring Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By End User

8. Asia-Pacific Cerebral Oximetry Monitoring Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cerebral Oximetry Monitoring Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By End User
  • 8.3.2. India Cerebral Oximetry Monitoring Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By End User
  • 8.3.3. South Korea Cerebral Oximetry Monitoring Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By End User
  • 8.3.4. Japan Cerebral Oximetry Monitoring Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Cerebral Oximetry Monitoring Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By End User

9. South America Cerebral Oximetry Monitoring Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cerebral Oximetry Monitoring Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Cerebral Oximetry Monitoring Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Cerebral Oximetry Monitoring Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By End User

10. Middle East and Africa Cerebral Oximetry Monitoring Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cerebral Oximetry Monitoring Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Cerebral Oximetry Monitoring Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Cerebral Oximetry Monitoring Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Masimo Corp.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Medtronic Plc
• 15.3. Edwards Lifesciences Corporation
• 15.4. Nonin Medical Inc.
• 15.5. ISS Inc.
• 15.6. Hamamatsu Corporation
• 15.7. Mespere LifeSciences, Inc.
• 15.8. GE HealthCare Technologies, Inc.
• 15.9. Terumo Cardiovascular Systems Corporation
• 15.10. Koninklijke Philips N.V.

16. Strategic Recommendations

17. About Us & Disclaimer